BroMocriptine IMpurity F Chemical Properties

Boiling point:

891.3±65.0 °C(Predicted)

Density 

1.52±0.1 g/cm3(Predicted)

pka

9.60±0.60(Predicted)

InChIKey

OZVBMTJYIDMWIL-CCCBMRMVNA-N

SMILES

C1[C@@H](C(N[C@@]2(O[C@@]3(N([C@H](C(N4[C@@]3([H])CCC4)=O)CC(C)C)C2=O)O)C(C)C)=O)CN(C)[C@]2(C=1C1=C3C(C2)=C(Br)NC3=CC=C1)[H] |&1:1,4,6,8,11,31,r|

BroMocriptine IMpurity F Usage And Synthesis

Description

Bromocriptine impurity F (chemical name: (6aR,9R)-5-Bromo-N-[(2S,5S,10aS,10bS)-10b-hydroxy-2-(1-methylethyl)-5-(2-methylpropyl)-3,6-dioxooctahydro-8H-oxazolo[3,2-a]pyrrolo[2,1-c]pyrazin-2-yl]-7-methyl-4,6,6a,7,8,9-hexahydroindolo[4,3-fg]quinoline-9-carboxamide) is an impurity of Bromocriptine. Bromocriptine is in a class of medications called dopamine receptor agonists. It treats hyperprolactinemia by decreasing the amount of prolactin in the body. It treats acromegaly by decreasing the amount of growth hormone in the body. It treats Parkinson's disease by stimulating the nerves that control movement.

BroMocriptine IMpurity F(82773-21-5)Related Product Information

• (8S)-2-BroMo α-Ergocryptine
• Bromocriptine Impurity 2
• ALPHA-ERGOCRYPTINE
• 5'alpha(S)-sec-butyl-12'-hydroxy-2'-isopropylergotaman-3',6',18-trione
• Ergotaman-3',6',18-trione, 2-bromo-12'-hydroxy-2'-(1-methylethyl)-5'-(2-methylpropyl)-, (2'β,5'α,8α)- (9CI)
• BroMocriptine IMpurity G
• Bromocriptine
• Bromocriptine mesylate
• BroMocriptine-13C-d3
• Ergoline-8-carboxylic acid, 2-bromo-9,10-didehydro-6-methyl-, (8β)-
• Bromocriptine Impurity A (Mixture of Diastereomers)
• BroMocriptine IMpurity E